Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02211651 · ClinicalTrials.gov registry record
Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)
A clinical trial, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- 3
- Enrollment target
NCT02211651: Completed study, sponsored by AdventHealth Translational Research Institute.
NCT02211651 is a clinical trial that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02211651 has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to discover the characteristics of pregnant women which increases risk for their babies to develop diabetes, later on in life.
Primary Outcome
Measurements will be immunohistochemistry and measured from placental tissue. Neonate's anthropometrics and sex will be recorded within 48 hours of the delivery by the Pediatrician and will last approximately 15 minutes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-01 |
What the finished NCT02211651 record still lists
NCT02211651 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02211651 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02211651 about?
NCT02211651 is a clinical study titled "Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)". The purpose of this study is to discover the characteristics of pregnant women which increases risk for their babies to develop diabetes, later on in life.
What is the current status of trial NCT02211651?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2013-12. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT02211651?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia